WP
ROIV icon

Woodline Partners’s Roivant Sciences ROIV Stock Holding History

Woodline Partners’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$48.5M Hold
1,750,017
– – 0.18% 143
2025
Q4 		$38M Sell
1,750,017
-1,315,573
-43% -$26M 0.15% 180
2025
Q3 		$46.4M Sell
3,065,590
-934,443
-23% -$11.6M 0.22% 124
2025
Q2 		$45.1M Sell
4,000,033
-1,253,323
-24% -$13.6M 0.24% 117
2025
Q1 		$53M Sell
5,253,356
-878,592
-14% -$9.5M 0.34% 77
2024
Q4 		$72.5M Sell
6,131,948
-2,554,528
-29% -$30.2M 0.49% 38
2024
Q3 		$100M Buy
8,686,476
+685,537
+9% +$7.8M 0.84% 19
2024
Q2 		$84.6M Sell
8,000,939
-3,171,367
-28% -$34.8M 0.81% 22
2024
Q1 		$118M Buy
11,172,306
+5,020,539
+82% +$54.1M 1.08% 11
2023
Q4 		$69.1M Sell
6,151,767
-1,022,486
-14% -$9.97M 0.75% 29
2023
Q3 		$83.8M Buy
7,174,253
+3,377,382
+89% +$38.2M 0.98% 19
2023
Q2 		$38.3M Buy
3,796,871
+236,320
+7% +$2.11M 0.45% 55
2023
Q1 		$26.3M Sell
3,560,551
-1,145,434
-24% -$9.43M 0.36% 85
2022
Q4 		$37.6M Buy
4,705,985
+2,206,650
+88% +$12.3M 0.5% 40
2022
Q3 		$8.05M Buy
+2,499,335
New +$9.68M 0.11% 224

Other funds holding ROIV

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
QF
QVT Financial New York $1.37B AUM 148.1% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Woodline Partners's ROIV Position: Q1 2026 in Review

Woodline Partners held its Roivant Sciences (ROIV) position steady in Q1 2026 at 1,750,017 shares worth $48.5M. The position accounts for 0.18% of the portfolio, ranked #143.

Woodline Partners first reported a position in ROIV in Q3 2022 and has held it in 15 quarters since. The position peaked at $118M in Q1 2024. 439 funds tracked by Wall St. Rank hold ROIV as of Q1 2026.

  • Woodline Partners held 1,750,017 shares of Roivant Sciences worth $48.5M as of Q1 2026.
  • Woodline Partners left its Roivant Sciences share count unchanged in Q1 2026.
  • Roivant Sciences made up 0.18% of Woodline Partners's portfolio in Q1 2026, its #143 holding.
  • Woodline Partners first reported a position in Roivant Sciences in Q3 2022 and has held it in 15 quarters since.
  • Woodline Partners's Roivant Sciences position peaked at $118M in Q1 2024.
  • 439 funds tracked by Wall St. Rank held Roivant Sciences as of Q1 2026.

Based on Woodline Partners's 13F filing for Q1 2026, filed 15 May 2026.